Atlas Trials

Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas

Clinical trial NCT01158651 · COMPLETED

Trial details

NCT number
NCT01158651
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioma
Start date
2010-07-10
Primary completion
2014-09-04
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.